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Putative Mechanisms of action
A. Esteban-Fernández1,2, C. Rendeiro3, J. P. E. Spencer2, D. Gigorro del Coso1,  
M. D. González de Llano1, B. Bartolomé1 and M. V. Moreno-Arribas1*
1 Instituto de Investigación en Ciencias de la Alimentación (CIAL), CSIC-UAM, Madrid, Spain, 2 Department of Food and 
Nutritional Sciences, School of Chemistry, Food and Pharmacy, University of Reading, Reading, UK, 3 Beckman Institute for 
Advanced Science and Technology, University of Illinois Urbana–Champaign, Champaign, IL, USA
Moderate wine consumption has shown the potential to delay the onset of neurode-
generative diseases. This study investigates the molecular mechanisms underlying the 
protective effects of wine-derived phenolic and aroma compounds in a neuroinflam-
mation model based on SIN-1 stress-induced injury in SH-SY5Y neuroblastoma cells. 
Cell pretreatment with microbial metabolites found in blood after wine consumption, 
3,4-dihydroxyphenylacetic (3,4-DHPA), 3-hydroxyphenylacetic acids and salicylic 
β-d-O-glucuronide, at physiologically concentrations (0.1–10 μM) resulted in increased 
cell viability versus SIN-1 control group (p <  0.05). Results also showed significant 
decreases in mitogen-activated protein kinase (MAPK) p38 and ERK1/2 activation as well 
as in downstream pro-apoptotic caspase-3 activity by some of the studied compounds. 
Moreover, pretreatment with p38, MEK, and ERK1/2-specific inhibitors, which have a 
phenolic-like structure, also resulted in an increase on cell survival and a reduction on 
caspase-3 activity levels. Overall, these results contribute with new evidences related to 
the neuroprotective actions of wine, pointing out that wine-derived human metabolites 
and aroma compounds may be effective at protecting neuroblastoma cells from nitrosa-
tive stress injury by inhibiting neuronal MAPK p38 and ERK1/2, as well as downstream 
caspase 3 activity.
Keywords: wine, polyphenols, gut phenolic metabolites, aroma compounds, mitogen-activated protein kinase, 
neuroprotection
Abbreviations: 3,4-DHPA, 3,4-dihydroxyphenylacetic acid; 4HPP, 3-(4-hydroxyphenyl) propionic acid; 3HPP, 3-(3-hydroxy-
phenyl) propionic acid; 3HPA, 3-hydroxyphenylacetic acid; SIN-1, 3-morpholinosydnonimine; MAPK, mitogen-activated 
protein kinases.
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inTrODUcTiOn
Oxidative and nitrosative stress play important roles in the 
development of neurodegenerative diseases such as Alzheimer’s 
and Parkinson’s (1). While the harmful effects of heavy alcohol 
intake are well-established (2), several epidemiological studies 
have suggested that low to moderate consumption of red wine 
(~250  mL per day) can be beneficial in delaying the onset of 
cognitive impairments in aging and neurodegenerative diseases 
(3–8). In agreement with this, evidence from human randomized 
controlled trials shows that acute supplementations with specific 
wine compounds, such as anthocyanins or flavonoids, report 
improvements in recognition and working memory, attention, and 
psychomotor function (5, 9). Moreover, in vivo studies in rodent 
models further support the idea that moderate red wine intake 
can impact cognitive function (10–12). In particular, replacement 
of water with a red wine (20% ethanol v/v) enriched in flavan-
3-ols (0.003–1.53  g/L) and anthocyanins (0.648  g/L), resulted 
in an improved cognitive performance when compared to 20% 
ethanol control group in rodents (10). Similarly, the intake of red 
wine during 7 months showed to be protective in an Alzheimer’s 
mice model, resulting in a reduction of cognitive deterioration 
and neuropathology, as measured by spatial memory tests and Aβ 
peptides clearance in Tg2576 mice (11, 12).
Red wine is a complex matrix rich in polyphenols, in particular 
flavan-3-ols, and also an important source of aroma compounds. 
Flavan-3-ols are metabolized in the human colon by microbial 
catabolism reactions (i.e., hydrolysis, oxidation), originating 
metabolites such as propionic acid, phenylacetic acid, and 
benzoic acids derivatives (13). Further metabolism in the liver 
results in an extensive conjugation into glucuronides, sulfates, 
and O-methyl derivatives. More importantly, these metabolites 
have been detected in human plasma at physiological micromolar 
concentrations following red wine intake (14). Several studies 
have further demonstrated an ability of gut-derived metabolites 
to cross the blood–brain barrier (BBB) both in in vitro and in vivo 
models (15–17), suggesting that these might be responsible of the 
described protective effects of red wine polyphenols in brain func-
tion and cognitive performance. On the other hand, wine aroma 
compounds, such as linalool and 1,8-cineole, have been exten-
sively described for their antioxidant, anti-inflammatory, and 
antimicrobial properties in in vitro models (18, 19). Interestingly, 
wine-derived aroma compounds are small lypophilic molecules, 
which have also been shown to cross the BBB and might equally 
contribute to beneficial effects in the central nervous system (20), 
although the underlying mechanism of action has not been fully 
characterized (21, 22).
Despite the increasing evidence of the potential of red-wine 
polyphenols to affect brain function, the underlying mechanisms 
by which these compounds might influence neuronal function 
remain to be established (23). Both, in vitro and in vivo studies 
suggest an ability of polyphenols, such as flavonoids, to interact 
with signaling pathways that modulate neuronal stress-induced 
apoptosis (24), including the nuclear factor-ĸB or mitogen-acti-
vated protein kinase (MAPK) pathways (in particular ERK1/2, 
JNK, and p38) (23, 24). These are known to activate downstream 
signals, such as STAT-1 (activator of transcription-1), related 
to pro-inflammatory responses in neurons (25, 26) as well as 
caspase-3 proteases activity, pro-apoptotic marker of cell death 
(27). While the interaction of flavonoids with such signaling 
pathways has been previously studied (1, 28), the effect of the 
physiological relevant human gut-derived metabolites (par-
ticularly phenolic acids) in neuronal function has been poorly 
explored.
3-Morpholinosydnonimine (SIN-1), a peroxynitrite genera-
tor described as inducing phosphorylation of protein tyrosine 
residues in brain cells (29), has been used as a neuronal damage 
inductor. It is able to produce peroxynitrite (ONOO−) from 
nitrogen monoxide (NO) and superoxide anion ( )O2
⋅− . ONOO− 
is one of the most reactive species implicated in causing 
damage in several cellular functions (i.e., oxidation of DNA, 
lipids, and protein sulfhydryls or the nitration of DNA and 
tyrosine) (30). In the present study, SIN-1-induced nitrosative 
stress in a human neuroblastoma cell line (SH-SY5Y) was used 
as a model of neuroinflammation (29, 30) in order to study 
the protective effects of wine-derived human gut metabolites, 
mainly phenolic compounds (3,4-dihydroxyphenylacetic, 
3-(4-hydroxyphenyl)propionic, 3-hydroxyphenylacetic (3HPA), 
and 3-(3-hydroxyphenyl) propionic acid, salicylic acid, β-d-O-
glucuronide of salicylic acid) and aroma compounds (linalool 
and 1,8-cineole) on neuronal survival, as well as their ability 
to interact with MAPK pathways (ERK1/2, JNK, p38) and 
downstream signaling processes (STAT 1, caspase-3).
eXPeriMenTal
chemicals
3,4-Dihydroxyphenylacetic acid (3,4-DHPA) and 3-(3-hydroxy-
phenyl) propionic acid (3HPP) were purchased from Alfa 
Aesar (Ward Hill, MA, USA). 3-(4-hydroxyphenyl) propionic 
acid (4HPP) was obtained from Sigma-Aldrich (Saint Louis, 
MO, USA), and 3HPA was purchased from Merck (Darmstadt, 
Germany). Salicylic acid (2-hydroxybenzoic acid) and its β-d-
O-glucuronide were from NE Scientific (Natick, MA, USA). 
Linalool and 1,8-cineole were purchased in Sigma-Aldrich 
(Saint Louis, MO, USA). Stock solutions of these compounds 
were freshly prepared and filtered (0.22  μM) in sterile PBS 
(1,000  μM). 3-Morpholinosydnonimine (SIN-1) was acquired 
from Alexis Biochemicals, Enzo Life Sciences (Exeter, UK). Anti-
GADPH was obtained from New England Biolabs (Hitchin, UK). 
Primary rabbit polyclonal antibodies specific for MAPK signal-
ing including total SAPK/JNK and phospho-SAPK/JNK (Thr183/
Tyr185), total p38 and phospho-p38 (Thr180/Tyr182), total ERK1/2 
and phospho-ERK1/2 (Thr202/Tyr204), and for total STAT-1 and 
phospho-STAT-1 (Tyr701) were from New England Biolabs 
(Hitchin, UK). Horseradish peroxidase (HRP)-conjugated 
goat anti-rabbit secondary antibody was obtained from Sigma-
Aldrich (Saint Louis, MO, USA). ECL® reagent and Hybond 
nitrocellulose membrane were purchased from Amersham 
Biosciences (Amersham, UK). All tissue culture reagents were 
purchased from Lonza (Slough, UK) and Invitrogen (Paisley, 
UK). MTT reagent was obtained from Sigma-Aldrich (Saint 
Louis, MO, USA).
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cell culture
SH-SY5Y (ATCC® CRL2266™) human neuroblastoma cell line 
was purchased from the American Type Culture Collection. Cells 
were routinely grown in 75 cm2 flasks in a mixture of Dulbecco’s 
modified Eagle Medium and Ham’s F12 (1:1 v/v) (Lonza, Slough, 
UK) supplemented with 10% fetal bovine serum, antibiotics 
(100  IU/mL penicillin and 100  μg/mL streptomycin) and 1% 
non-essential aminoacids (37°C and 5% CO2). Twenty-four hours 
prior to the experiments, cells were detached from flasks with 
trypsin-EDTA solution (Sigma-Aldrich, Saint Louis, MO, USA) 
and seeded on the respective plates.
assessment of cell Viability
Neuronal cells (4.105 cells/mL) were seeded on 96-well plates 
24  h prior to the incubation with the phenolic acids and 
aroma compounds (0.1–10 μM). After 18 h, cells were washed 
twice with DPBS solution (Lonza, Slough, UK) and Thiazolyl 
Blue Tetrazolium Bromide reagent (MTT) (0.5  mg/mL, final 
concentration) (Sigma-Aldrich, Saint Louis, MO, USA) was 
added. Then, plates were returned to the incubator (37°C, 5% 
CO2) for 3 h. Supernatant was carefully removed and formazan 
crystals were dissolved with pure DMSO before absorbance was 
measured (570 nm) on a Multiskan multiplate reader (Thermo 
Fisher, Waltham, MA, USA). Control (no compound added) 
was considered as maximum of percentage of viability (100%), 
and the sample values were calculated as: % viability = (Abssample/
Abscontrol) × 100. Assays were performed in triplicate.
neuroprotective effect against  
sin-1-induced cell Death
3-morpholinosydnonimine (SIN-1), a peroxynitrite generator 
has been used as a neuronal damage inductor. For the assays, 
neuronal cells (4 × 105 cells/mL) were seeded on 96-well plates 
24 h prior to the incubation with the phenolic acids and aroma 
compounds (0.1–10 μM; 18 h). Then, neuroblastoma cells were 
exposed to freshly prepared 1 mM SIN-1 for 0–15 h (37°C, 5% 
CO2) and MTT reagent was added (0.5  mg/mL). Plates were 
returned to the incubator for 3 h, and assay was performed as 
described above.
For MEK (PD98059, Calbiochem), p38 (SB203580, 
Calbiochem), and ERK (FR180204, Sigma-Aldrich) inhibitors, 
the same procedure was applied with the exception that neuro-
blastoma cells were pretreated for 1 h with different concentra-
tions of inhibitor (0.5–50  μM) prior the exposition to freshly 
prepared SIN-1 (1 mM) during 0–15 h. Assays were carried out 
in triplicates.
Modulation of MaPK signaling Pathway
To determine the ability of the phenolic acids and aroma com-
pounds to modulate SIN-1-induced MAPK and STAT-1 phos-
phorylation, neuronal cells (106 cells/mL) were seeded on 6-well 
plates 24 h prior to incubation with the compounds (0.1–10 μM; 
18 h). After this time, cells were activated with SIN-1 (500 μM) for 
1–2 h. Then, neuronal cells were first washed with ice-cold PBS 
with 200 μM EGTA and 200 μM EDTA and lysed on ice using 
50 mM Tris, 0.1% Triton X-100, 150 mM NaCl, and 2 mM EGTA/
EDTA, containing Complete® Protease Inhibitor Cocktail tablets 
and PhosStop® Phosphatase Inhibitor Cocktail Tablets (Roche, 
Basel, Switzerland). Lysed cells were scraped, left on ice to solu-
bilize for 45 min, and total protein concentration was determined 
by BCA assay (Pierce Kit, Thermo Scientific, Rockford, IL, USA) 
to normalize protein level. Samples were frozen at −80°C until 
further immunoblotting analysis.
Western immunoblotting
Immunoblotting was performed as previously described (25). 
Samples (20  μg protein/lane) were run on 10% pre-cast SDS-
polyacrylamide gels (Bio-Rad, Hemel Hempstead, UK), and pro-
teins were transferred to nitrocellulose membranes (Hybond-ECL) 
(Amersham, Buckinghamshire, UK) by semi-dry electroblotting 
(0.8 mA/cm2). Blots were incubated overnight at 4°C, with the 
primary antibodies described above (all 1:1,000 dilution) in Tris–
Tween Buffered Saline (TTBS) containing 1% (w/v) skimmed 
milk powder antibody buffer, on a three-dimensional rocking 
table. Afterward, the blots were washed with TTBS, incubated 
with goat anti-rabbit IgG conjugated to HRP secondary antibody 
(1:1,000 dilution) for 45 min, washed with TTBS and then exposed 
to ECL-reagent® for 1.5 min and developed using ImageQuant™ 
LAS mini 4000 (GE Healthcare, Buckinghamshire, UK). Bands 
were analyzed using ImageQuant™ Software (GE Healthcare, 
Buckinghamshire, UK). Molecular weights of the bands were 
calculated from comparison with prestained molecular weight 
markers (MW 10–250  kDa) (BioRad, Hemel Hempstead, UK), 
which were run in parallel with the samples. The equal loading 
and efficient transfer of proteins was confirmed by using GADPH 
as internal control.
caspase-3 activity
Neuroblastoma cells (106 cells/mL) were seeded on 6-wells plates 
24 h prior the pretreatment with wine constituents (0.1–10 μM; 
18 h) or MAPK inhibitors (0.5–50 μM; 1 h) exposure to SIN-1 
(1  mM; 6  h). Culture was then washed twice with ice-cold 
PBS + EGTA + EDTA (200 μM), and the cells were lysed and 
collected as previously described. The activity of caspase-3-like 
proteases in the lysates was determined using the caspase-3 
colorimetric assay kit (Sigma, Poole, Dorset, UK) according 
to the manufacturer’s protocol, with the exception that 30  μL 
of cell lysate was used in assays. Absorbance data (405  nm) 
obtained using the caspase-3 inhibitors were subtracted from 
the absorbance obtained without caspase-3 inhibitor to correct 
for any non-specific hydrolysis. Vehicle controls and blanks were 
incorporated, and caspase-3 protein was used as a positive control 
of the assay. Assays were carried out in triplicates.
statistical analysis
Data were expressed as the mean ± SEM of three independent 
experiments. Statistical analysis was made using one-way analy-
sis of variance, followed by a post hoc Dunnett test of each time 
point to look for significant differences with respect to SIN-1 
condition (positive control). Significance level was set at p < 0.05. 
Statistics analysis was carried out using STATISTICA program 
for Windows, version 7.1 (StatSoft. Inc., 1984–2006).
FigUre 1 | neuroprotective effects of phenolic acids (a–F) and aroma compounds (g,h) against sin-1-induced damage in sh-sY5Y cells. Following 
pretreatment with wine compounds (0.1–10 μM) or media (control) for 18 h, cells were exposed to SIN-1 (1 mM) for 0–15 h, before assessment of viability (%) by 
MTT assay. Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significantly different from 
SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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resUlTs
ability of Phenolic acids and aroma 
compounds to Protect neuroblastoma 
cells against sin-1-induced neurotoxicity
None of the selected compounds (0.1–10  μM) affected cell 
viability (%) (data not shown) in relation to the control (no 
added compound). Pretreatment with 10  μM 3,4-DHPA acid 
resulted in a significant increase in cell viability against SIN-
1-induced neuronal death (Figure  1A) when compared to the 
SIN-1 control group, regardless of the length of time of exposure 
to SIN-1 (4 h: p < 0.01; 6–15 h: p < 0.001). The lower concentra-
tions of 3,4-DHPA (<10 μM) were also effective, but only during 
reduced time exposures to SIN-1 (4  h: p <  0.001). Significant 
protective actions were also observed for 4HPP (10 μM; p < 0.01) 
(Figure  1B); 3HPP (10 μM, p <  0.05) (Figure  1C) and 3HPA 
(0.1–10 μM, p < 0.05) (Figure 1D), when SIN-1-induced toxicity 
was less prolonged (4–6 h). A similar trend was observed for both 
salicylic acid (Figure 1E) and its glucuronide (Figure 1F), which 
were shown to be protective against SIN-1 after 4  h exposure, 
but innefective for longer periods (6–15 h). All concentrations 
of glucuronide of salicylic acid tested were effective at maintain-
ing cell viability after 4 h of SIN-1 exposure (0.1 μM, p < 0.001; 
1–10 μM, p < 0.05) (Figure 1F), while for salicylic acid, only 1 μM 
concentration resulted in a significant increase in cell survival 
(p < 0.05) (Figure 1E).
Aroma compounds 1,8-cineole and linalool (Figures 1G,H) 
showed a neuroprotective effect at specific concentrations and 
specific times of exposure. 1,8-Cineole was able to increase cell 
viability after 9 h SIN-1 incubation (p < 0.01) (Figure 1G), while 
linalool was only effective after shorter periods of SIN-1 exposure 
(4 h; p < 0.05) (Figure 1H).
effect of Phenolic acids and aroma 
compounds on sin-1-induced p38 
Phosphorylation
Exposure of SH-SY5Y cells to SIN-1 (1 h in all the cases, except for 
salicylic acid and its glucuronide that was exposed for 2 h; 500 μM) 
FigUre 2 | inhibition of p38 phosphorylation in sin-1 activated sh-sY5Y cells. Cells were treated with SIN-1 (500 μM) for 1 h in all the cases except for 
salicylic acid and its glucuronidie that was exposed for 2 h, after being pretreated with wine compounds (0.1–10 μM) for 18 h. Crude homogenates (20 μg) were 
immunoblotted with antibodies that detect endogenous levels of p38 only when phosphorylated. Data obtained from immunoblot experiments with p38 were 
analyzed using Image Quant LAS 4000 mini software, and each column represents the mean ± SEM of three independent experiments. (a) Phosphorylation status 
of p38 after incubation with phenolic acids [DHPA, 4HPP, 3HPP, and 3-hydroxyphenylacetic (3HPA)]. 1: control; 2: SIN-1; 3–5: DHPA (0.1, 1, and 10 μM, 
respectively); 6–8: 4HPP (0.1, 1, and 10 μM, respectively); 9–11: 3HPP (0.1, 1, and 10 μM, respectively); 12–14: 3HPA (0.1, 1, and 10 μM, respectively). * Indicates 
values significant different (p < 0.05) from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test.  
(B) Phosphorylation status of p38 after incubation with salicylic acid and its glucuronide. 15: control; 16: SIN-1; 17–19: salicylic acid (0.1, 1, and 10 μM, 
respectively); 20–22: β-d-O-glucuronide (0.1, 1, and 10 μM, respectively). * Indicates values significant different (p < 0.06) from SIN-1 group as analyzed by one-way 
ANOVA followed by Dunnett comparison test. (c) Phosphorylation status of p38 after incubation with aroma compounds. 23: control; 24: SIN-1; 25–27 linalool (0.1, 
1, and 10 μM, respectively); 28–30 1,8-cineole (0.1, 1, and 10 μM, respectively). *p < 0.05 indicates values significant different (except p < 0.06 in the case of 
control) from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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resulted in a significant increase in the phosphorylation of p38 
when compared to the control (p < 0.05) (Figure 2). Treatment 
of the cells with wine-derived compounds (0.1–10 μM for 18 h) 
prior to exposure to SIN-1 only resulted in a significant inhibition 
of p38 phosphorylation status for 4HPP (p <  0.01) and 3HPA 
(p < 0.05) at the lower concentration (0.1 μM) (Figures 2A,B). 
The aroma compound 1,8-cineole also exerted a significant inhi-
bition of p38 at all concentrations tested (0.1–10 μM; p < 0.05) 
(Figure 2C).
effect of Phenolic acids and aroma 
compounds on sin-1-induced erK1/2 
Phosphorylation
Exposure of neuroblastoma cells to SIN-1 (1 h; 500 μM) leads to a 
significant increase of ERK1/2 phosphorylation when compared 
to the control (p <  0.05) (Figures  3 and 4). Pretreatment with 
wine-derived phenolic acids 3,4-DHPA, 4HPP, 3HPP, and 3HPA 
resulted in a significant decrease in ERK1/2 phosphorylation at all 
FigUre 4 | inhibition of erK1/2 phosphorylation in sin-1 activated sh-sY5Y cells. (a) Data obtained from immunoblot experiments with ERK1 were 
analyzed using Image Quant LAS 4000 mini software and each column represents the mean ± SEM of three independent experiments. *p < 0.05 indicates values 
significant different from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Data obtained from 
immunoblot experiments with ERK2 were analyzed using Image Quant™ Software, and each column represents the mean ± SEM of three independent 
experiments. *p < 0.05 indicates values significant different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test. (c) Western 
blot of the aroma compounds (linalool and 1,8-cineole) inhibition of ERK1/2 phosphorylation in SIN-1-activated neuronal cells. Cells were treated with SIN-1 
(500 μM) for 1 h after being pretreated with aroma compounds (0.1–10 μM) for 24 h. Crude homogenates (20 μg) were immunoblotted with antibodies that detect 
endogenous levels of ERK 1/2 only when phosphorylated. 1: control; 2: SIN-1; 3–5: linalool (0.1, 1, and 10 μM, respectively); 6–8: 1,8-cineole (0.1, 1, and 10 μM, 
respectively).
FigUre 3 | inhibition of erK1/2 phosphorylation in sin-1 activated sh-sY5Y cells. (a) Data obtained from immunoblot experiments with ERK1 were 
analyzed using Image Quant LAS 4000 mini software and each column represents the mean ± SEM of three independent experiments. *p < 0.05, **p < 0.01 
indicate values significant different from SIN-1 group as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Data obtained 
from immunoblot experiments with ERK2 were analyzed using Image Quant™ Software, and each column represents the mean ± SEM of three independent 
experiments. *p < 0.05, **p < 0.01 indicate values significant different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.  
(c) Western blot of the phenolic acids (DHPA, 4HPP, 3HPP, and 3-hydroxyphenylacetic (3HPA)) inhibition of ERK1/2 phosphorylation in SIN-1-activated neuronal 
cells. Cells were treated with SIN-1 (500 μM) for 1 h after being pretreated with phenolic acids (0.1–10 μM) for 24 h. Crude homogenates (20 μg) were 
immunoblotted with antibodies that detect endogenous levels of ERK 1/2 only when phosphorylated. 1: control; 2: SIN-1; 3–5: DHPA (0.1, 1, and 10 μM, 
respectively); 6–8: 4HPP (0.1, 1, and 10 μM, respectively); 9–11: 3HPP (0.1, 1, and 10 μM, respectively); 12–14: 3HPA (0.1, 1, and 10 μM, respectively).
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concentrations tested (p < 0.01), reaching similar levels as control 
(Figure 3). Similarly, the aroma compounds, linalool and 1,8-cin-
eole exerted a significant reduction in ERK1/2 activation (at all 
concentrations tested) (p < 0.05) in relation to the SIN-1 group 
(Figure 4). Regarding salicylic acid and its glucuronide, no modu-
latory effect over ERK1/2 phosphorylation was observed (data not 
shown). We observed no modulation of JNK and STAT-1 by SIN-1 
or any of the wine-derived compounds tested (data not shown).
FigUre 5 | relative activity of caspase-3 protein (%) in sh-sY5Y cells after sin-1-induced damage. Cells were pretreated with phenolic (a–F) and aroma 
compounds (g,h) or media (control) for 18 h before SIN-1 incubation. After 6 h exposure, cells were washed, scraped, and lysed. Lysates were analyzed by 
Caspase-3 colorimetric assay. Data are indicated as% of caspase-3 activity, considering SIN-1 group the maximum activity for this protein (100%). Results are 
expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significant different from SIN-1 group as analyzed 
by one-way ANOVA followed by Dunnett comparison test.
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effect of Phenolic acids and aroma 
compounds in caspase-3 activation 
Following sin-1-induced neuronal 
Damage
Treatment of SH-SY5Y cells with SIN-1 (6 h; 1 mM) resulted in a 
significant increase of caspase-3 activation in relation to control 
(p < 0.001) (Figure 5). When administered at 10 μM, phenolic 
acid 3HPP reduced significantly caspase-3 activation (p < 0.01) 
in relation to SIN-1 control (Figure 5C). The aroma compound 
linalool (1, 10 μM) also showed a significant reduction (p < 0.01 
and p < 0.001, respectively) in the activation of caspase-3 in rela-
tion to SIN-1-treated cells (Figure 5H).
effect of MaPK signaling inhibitors in cell 
Viability and caspase-3 activation after 
sin-1-induced neuronal Damage
Inhibition of ERK1/2 (FR180204) and upstream MEK1 (PD98059) 
significantly increased cell viability (p < 0.05), with the highest 
concentration tested being the most effective (50  μM) against 
(4–15 h) SIN-1-induced toxicity (Figure 6A). Inhibition of p38 
(SB203580) resulted in an increased of cell viability (at 4 h SIN-1 
incubation) only when administered at the highest concentration 
(50 μM) (p < 0.05) (Figure 6A).
Furthermore, inhibition of p38, MEK, and ERK1/2 resulted 
in an overall significant reduction of caspase-3 activation, which 
confirms that SIN-1-induced MAPK signaling is linked to the 
activation of caspase-3 protein (Figure 6B). Specifically, p38 inhi-
bition consistently decreased caspase-3 protein activation, with 
all the concentrations tested being equally effective (p < 0.001). 
For MEK and ERK1/2 not all concentrations resulted in a signifi-
cant reduction in caspase-3 activity. In particular, MEK inhibitor 
concentrations were effective in reducing caspase-3 activity only 
when administered at 0.5 and 5 μM (p <  0.05), while ERK1/2 
inhibitor doses were effective at 0.5 and 50 μM (p < 0.01).
DiscUssiOn
Specific wine-derived phenolic compounds were selected for the 
present study given their bioavailability in urine and feces after 
moderate and regular wine consumption in humans (31, 32). In 
support of our model, Gasperotti and colleagues (16) recently 
FigUre 6 | (a) Neuroprotective effects of p38 inhibitor (SB203580), MEK inhibitor (PD98059), and ERK inhibitor (FR180204) against SIN-1-induced damage in 
SH-SY5Y cells. Following pretreatment with inhibitors for 1 h or media (control), cells were exposed to SIN-1 (1 mM) for 0–15 h, before assessment of viability by 
MTT assay. Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significantly different from 
SIN-1 group (zero) as analyzed by one-way analysis of variance (ANOVA) followed by Dunnett comparison test. (B) Relative activity of Caspase-3 protein (%) in 
SH-SY5Y cells after SIN-1-induced damage. Cells were pretreated with inhibitors for 1 h before SIN-1 incubation. After 6 h exposure, cells were washed, scraped, 
and lysed. Lysates were analyzed by Caspase-3 colorimetric assay. Data are indicated as% of caspase-3 activity, considering SIN-1 group the maximum activity for 
this protein (100%). Results are expressed as means of three independent experiments ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 indicate values significant 
different from SIN-1 group as analyzed by one-way ANOVA followed by Dunnett comparison test.
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reported that phenolic acids 3HPA, 3,4-DHPA, and HPP were 
present in the brain of rats following intake of 23 polyphenol 
microbial metabolites. Similarly, Wang et al. (17) observed that 
3-hidroxybenzoic acid and 3HPP were also accumulated in 
rodent brains at μM concentrations after orally administration of 
grape seed polyphenols extract. Altogether, this strongly suggests 
that microbial-derived phenolic acids can cross the BBB in vivo, 
and therefore, they have the potential to act centrally. The stress 
induced by SIN-1 led to a significant and time-dependent cell 
death in SH-SY5Y cell line. In a similar manner, SIN-1 treat-
ment resulted in a significant phosphorylation of ERK1/2 and 
p38 MAPK proteins, as well as downstream caspase-3 protein 
activation. In agreement with our results, other assays in the 
same cellular model have demonstrated that peroxynitrite is able 
to induce neuronal damage via ERK1/2 and p38 modulation, as 
well as to induce caspase-3 protein activation (29, 30, 33, 34), 
which validates our model.
In this study, 3,4-DHPA showed a strong protective effect 
against SIN-1 induced-cell death, especially at 10  μM. This is 
in agreement with previous studies where 3,4-DHPA, at similar 
doses (20  μM), completely blocked the effect of peroxynitrite 
on tyrosine hydroxylase, an enzyme involved in Parkinson’s 
disease pathology (35). Furthermore, recent evidences showed 
a preventive action of this phenolic metabolite in dysfunctional 
pancreatic-β-cells (36), even at not physiologically relevant 
concentrations (up to 250 μM), as well as on mice liver after intra-
gastrically administration of 3,4-DHPA (10, 20, or 50 mg/kg) for 
3 days (37). Additionally, in the meanline of the redaction process 
of this paper, new evidence was reported showing the ability of a 
panel of phenolic metabolites, noting 3,4-DHPA among them, to 
prevent neuronal death after oxidative (H2O2) induced injury in 
the SH-SY5Y cellular model at a similar range of concentrations 
(1–10 μM) (38). β-d-O-Glucuronide of salicylic acid also showed a 
significant neuroprotective effect in the present study, unlike what 
was observed for its aglycone as González-Sarrias et al. (38) also 
reported. In disagreement with the weaker ability to access cells 
of glucuronide forms (39), some studies proposed the possibility 
of β-glucuronidases cleaving the glucuronide form and releasing 
the free aglycone (40). Further significant reductions of cell death 
were also seen for 4HPP, 3HPP, 3HPA, linalool, and 1,8-cineole, 
particularly at shorter incubation times. In similar conditions, 
previous research showed a neuroprotective effect of champagne 
wine polyphenols, including gallic acid, caffeic acid, and tyrosol 
(0.1 and 10 μM) on primary cortical neurons (41) after SIN-1-
induced damage and after S-cysteinyl-dopamine toxin exposition 
(42), as well as (−)-epicatechin oligomers have been described to 
neutralize peroxynitrite damage (0–20 μM) (43).
When pro-inflammatory signals are triggered in the central 
nervous system following nitrosative stress, MAPK kinases, such 
as ERK1/2, JNK, and p38 (24), become phosphorylated, leading 
to the activation of transcription factors, such as STAT-1 (1), and 
favoring the activation of proteins related to cellular damage, 
inflammation, and apoptosis, such as caspase-3. p38 protein has 
been related to neuronal stress and the control of cell death and 
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survival (44), while the role of ERK1/2 on this balance is con-
troversial. This protein has been usually linked to a pro-survival 
function (45); however, several studies demonstrated a role of 
ERK1/2 on oxidative stress-induced apoptosis (33, 46–48). This is 
in agreement with our results, where an increase of pERK1/2 was 
observed after SIN-1 treatment. Additionally, the use of ERK1/2 
specific inhibitor resulted in an increase of cell viability after SIN-1 
induced-stress. All the phenylacetic and phenylpropionic acids 
(3,4-DHPA, 4HPP, 3HPP, and 3HPA) and aroma compounds 
(linalool and 1,8-cineole) tested showed a modulatory effect on 
SIN-1 induced-phosphorylation of ERK1/2. On the other hand, 
no modulation of ERK1/2 was observed for salicylic acid and its 
glucuronide, which might indicate that they act through alterna-
tive pathways, such as NF-κB, described to be modulated by a 
salicylic acid analog (49). In addition, 4HPP and 3HPA (0.1 μM), 
as well as 1,8-cineole (0.1–10 μM) also significantly modulated 
p38 phosphorylation. Several lines of research have demonstrated 
a modulation of MAPK by a wide range of polyphenols (24) 
especially, flavonoids (1, 24, 50). For instance, naringenin was 
able to modulate p38 phosphorylation (0.01–0.3 μM) in a neu-
roinflammation primary mixed glial cells model (25). Similarly, 
(−) epicatechin is also able to interact with JNK and ERK1/2 
at physiologically relevant concentrations to protect neurons 
against oxidative stress-induced death (51). However, these stud-
ies have mainly focused on the effects of aglycones (24), not in 
physiologically relevant microbial metabolites that are found in 
the circulation following polyphenols-rich food intake (38, 52). 
As exception, the protocatechuic acid (3,4-dihydroxybenzoic 
acid), was shown to modulate inflammation via modulation of 
BDNF, resulting in amelioration of cognitive deficits, as well as to 
attenuate amyloid deposits in aged AβPP/PS1 double transgenic 
mice (100  mg/kg/day during 4  weeks) (53). Regarding aroma 
compounds, both 1,8-cineole and linalool, have been previously 
described to modulate in  vitro stress-induced signaling path-
ways, such as NF-kB (21, 22). Concurrently, and in agreement 
with our results, 1,8-cineole was described to interact with p38 
MAPK protein in an asthma model of bronchial epithelial cells 
(54). These observations were in  vivo corroborated, with the 
exposure to 1,8-cineole resulting in better cognitive performance 
in a pilot clinical human study (n = 20) (20). Additionally, oral 
administration of linalool (25 mg/kg for 3 months) to Alzheimer’s 
triple transgenic mice showed a beneficial effect on behavioral 
FigUre 7 | Proposed scheme of the mitogen-activated protein kinase (MaPK) signaling cascade after a stress-induced phosphorylation in neurons 
and its implication in the balance of cell apoptosis and survival signals. Phosphorylation of MAPK (p38 or ERK) leads to the activation of several proteins, 
including caspase-3, and therefore resulting in a modification of the balance between apoptotic and pro-survival signals in neurons. The activation of MAPK could 
be modified by the action of wine constituents, including phenolic acids and aroma compounds.
10
Esteban-Fernández et al. Neuroprotective Effects of Wine Components
Frontiers in Nutrition | www.frontiersin.org March 2017 | Volume 4 | Article 3
reFerences
1. Spencer JPE, Vafeiadou K, Williams RJ, Vauzour D. Neuroinflammation: 
modulation by flavonoids and mechanisms of action. Mol Aspects Med (2012) 
33:83–97. doi:10.1016/j.mam.2011.10.016 
2. Hvidtfeldt UA, Frederiksen ME, Thygesen LC, Kamper-Jorgensen M, Becker 
U, Gronbaek M. Incidence of cardiovascular and cerebrovascular disease in 
Danish men and women with a prolonged heavy alcohol intake. Alcohol Clin 
Exp Res (2008) 32(11):1920–4. doi:10.1111/j.1530-0277.2008.00776.x 
3. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, 
et al. Wine consumption and dementia in the elderly: a prospective commu-
nity study in the Bordeaux area. Rev Neurol (1997) 153:185–92. 
4. Arntzen KA, Schirmer H, Wilsgaard T, Mathiesen EB. Moderate wine con-
sumption is associated with better cognitive test results: a 7 year follow up 
of 5033 subjects in the Tromsø Study. Acta Neurol Scand (2010) 122(Suppl 
190):23–9. doi:10.1111/j.1600-0404.2010.01371.x 
5. Stockley CS. Wine consumption, cognitive function and dementias – a rela-
tionship? Nutr Aging (2015) 3(2–4):125–37. doi:10.3233/NUA-150055 
6. Truelsen T, Thudium D, Grønbaek M; Copenhagen City Heart Study. Amount 
and type of alcohol and risk of dementia: the Copenhagen City Heart Study. 
Neurology (2002) 59(9):1313–9. doi:10.1212/01.WNL.0000031421.50369.E7 
7. Letenneur L. Risk of dementia and alcohol and wine consumption: 
a review of recent results. Biol Res (2004) 37(2):189–93. doi:10.4067/
S0716-97602004000200003 
8. Caruana M, Cauchi R, Vassallo N. Putative role of red wine polyphenols 
against brain pathology in Alzheimer’s and Parkinson’s disease. Front Nutr 
(2016) 3:31. doi:10.3389/fnut.2016.00031 
9. Bell L, Lamport DJ, Butler LT, Williams CM. A review of the cognitive effects 
observed in humans following acute supplementation with flavonoids, and 
their associated mechanisms of action. Nutrients (2015) 7(12):10290–306. 
doi:10.3390/nu7125538 
10. Assunção M, Santos-Marques MJ, De Freitas AV, Carvalho BF, Andrade 
CJP, Lukoyanova ANV, et  al. Red wine antioxidants protect hippocampal 
neurons against ethanol-induced damage: a biochemical, morphological 
and behavioral study. Neuroscience (2007) 146:1581–92. doi:10.1016/j.
neuroscience.2007.03.040 
11. Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, et  al. Heterogeneity 
in red wine polyphenolic contents differentially influences Alzheimer’s 
disease-type neuropathology and cognitive deterioration. J Alzheimers Dis 
(2009) 16:59–72. doi:10.3233/JAD-2009-0916 
12. Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, et  al. Moderate 
consumption of Cabernet Sauvignon attenuates A-beta neuropathology in a 
mouse model of Alzheimer’s disease. FASEB J (2006) 20:2313–20. doi:10.1096/
fj.06-6281com 
13. Monagas M, Urpi-Sarda M, Sánchez-Patán F, Llorach R, Garrido I, Gómez-
Cordovés C, et al. Insights into the metabolism and microbial biotransforma-
tion of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct 
(2010) 1:233–53. doi:10.1039/c0fo00132e 
14. Boto-Ordóñez M, Rothwell JA, Andres-Lacueva C, Manach C, Scalbert A, 
Urpi-Sarda M. Prediction of the wine polyphenol metabolic space: an appli-
cation of the Phenol-Explorer database. Mol Nutr Food Res (2014) 58:466–77. 
doi:10.1002/mnfr.201300411 
15. Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid 
permeability across an in  situ model of the blood-brain barrier. Free 
Radic Biol Med (2004) 36(5):592–604. doi:10.1016/j.freeradbiomed. 
2003.11.023 
16. Gasperotti M, Passamonti S, Tramer F, Masuero D, Guella G, Mattivi F, et al. 
Fate of microbial metabolites of dietary polyphenols in rats: is the brain their 
impairment, as well as a reduction in pro-inflammatory markers 
(p38 MAPK, NOS2, COX2, and IL-1β) (55).
Caspase-3 protein promotes stress-mediated apoptosis by 
endonucleases activation (27). Flavonoids, such as (−)-epicat-
echin (and some derivatives as 3′-O-methyl-epicatechin and 
(−)-epicatechin-glucuronide) and kaempferol were reported to 
reduce caspase-3 levels on cultured striatal neurons and fibroblasts 
(30 μM) (39, 56). We further observed significant reductions on 
downstream active caspase-3 levels after pretreatment with 3HPP 
and linalool, despite p38 activation levels were not affected. The 
observed fact of the reduction of p38 and ERK1/2 activation not 
being accompanied by an amelioration of caspase-3 activity has 
been also previously perceived in other in vitro models of induced 
stress (33). This could suggest that the most part of these com-
pounds are not able of affecting this point but also that caspase-3 
can become activated in several scenarios, such as mitochondrial 
damage and cytochrome c release (57).
Finally, we observed that pretreatment of MEK-, ERK1/2-, and 
p38-specific inhibitors with a phenolic-like structure resulted in 
an increase on cell survival and a reduction on caspase-3 levels. 
These were similar to the effects we observed for phenolic 
acids and the aroma compounds tested, suggesting that wine 
compounds could exert a neuroprotective effects by inhibiting 
ERK1/2 and p38, as well as by modulating downstream caspase-3 
protein. The application of specific MAPK inhibitors has been 
widely used with the aim of establishing mechanism of actions of 
polyphenols, based on its structural homology (24, 56).
In summary, in the present study, we demonstrate that 
specific wine-derived phenolic acids and aroma compounds, 
in particular 3,4-DHPA, are protective against neuronal death 
induced by SIN-1 in a dopaminergic cell line. Such protective 
actions are likely modulated via inhibition of ERK1/2 (for aroma 
compounds and all phenolic acids, except for salicylic acid and 
its glucuronide, which suggest other mechanisms of action for 
these compounds), and via modulation of p38 MAPK kinases 
(1,8-cineole, 4HPP, and 3HPA), as well as through down-
stream pro-apoptotic caspase 3 activation (3HPP and linalool) 
(Figure 7). In support of this, we further show that pharmaco-
logical inhibition of MEK/ERK and p38 in this model, results in 
similar protective effects on cell viability and also in a reduction 
of caspase 3 activation, strongly suggesting that protective actions 
of phenolic acids might be linked to these pathways.
aUThOr cOnTriBUTiOns
MM-A and BB conceived and designed the study, analyzed the 
data, and wrote the paper. AE-F and DC performed the experi-
ments, and AE-F participated in the redaction of the manuscript. 
JS, DC, and CR participated in the design and critical revision. All 
authors read and approved the final manuscript.
FUnDing
The study was supported by projects AGL2015-64522-C2-1-R 
from the Spanish Ministry of Economy and Competitiveness 
(MINECO), ALIBIRD-CM 2013 S2013/ABI-2728 (Comunidad 
de Madrid), and COST Action FA 1403 POSITIVe (“inter-
individual variation in response to consumption of plant food 
bioactives and determinants involved”). AE-F is a recipient of 
an FPI contract from the Spanish MINECO (Project AGL2012-
40172-C02-01). The FPI Internship programme made the devel-
opment of this work possible.
11
Esteban-Fernández et al. Neuroprotective Effects of Wine Components
Frontiers in Nutrition | www.frontiersin.org March 2017 | Volume 4 | Article 3
target destination? ACS Chem Neurosci (2015) 6(8):1341–52. doi:10.1021/
acschemneuro.5b00051 
17. Wang D, Ho L, Faith J, Ono K, Janle EM, Lachcik PJ, et al. Role of intestinal 
microbiota in the generation of polyphenol-derived phenolic acid mediated 
attenuation of Alzheimer’s disease β-amyloid oligomerization. Mol Nutr Food 
Res (2015) 59(6):1025–40. doi:10.1002/mnfr.201400544 
18. Liu K, Chen Q, Liu Y, Zhou X, Wang X. Isolation and biological activities 
of decanal, linalool, valencene, and octanal from sweet orange oil. J Food Sci 
(2012) 77(11):C1156–61. doi:10.1111/j.1750-3841.2012.02924.x 
19. de Cássia da Silveira e Sá R, Andrade LN, de Sousa DP. A review on 
anti-inflammatory activity of monoterpenes. Molecules (2013) 18:1227–54. 
doi:10.3390/molecules18011227 
20. Moss M, Oliver L. Plasma 1,8-cineole correlates with cognitive performance 
following exposure to rosemary essential oil aroma. Ther Adv Psychopharmacol 
(2012) 2(3):103–13. doi:10.1177/2045125312436573 
21. Li Y, Lv O, Zhou F, Li Q, Wu Z, Zheng Y. Linalool inhibits LPS-induced 
inflammation in BV2 microglia cells by activating Nrf2. Neurochem Res (2015) 
40(7):1520–5. doi:10.1007/s11064-015-1629-7 
22. Khan A, Vaibhav K, Javed H, Tabassum R, Ahmed ME, Khan MM, et  al. 
1,8-cineole (eucalyptol) mitigates inflammation in amyloid Beta toxicated 
PC12 cells: relevance to Alzheimer’s disease. Neurochem Res (2014) 39(2):344–
52. doi:10.1007/s11064-013-1231-9 
23. Ramassamy C. Emerging role of polyphenolic compounds in the treatment 
of neurodegenerative diseases: a review of their intracellular targets. Eur 
J Pharmacol (2006) 545:51–64. doi:10.1016/j.ejphar.2006.06.025 
24. Spencer JPE. The interactions of flavonoids within neuronal signaling path-
ways. Genes Nutr (2007) 2(3):257–73. doi:10.1007/s12263-007-0056-z 
25. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer 
JPE. The citrus flavanone naringenin inhibits inflammatory signaling in glial 
cells and protects against neuroinflammatory injury. Arch Biochem Biophys 
(2009) 484(1):100–9. doi:10.1016/j.abb.2009.01.016 
26. Chen JC, Ho FM, Chao PL, Chen CP, Jeng KC, Hsu HB, et al. Inhibition of 
iNOS gene expression by quercetin is mediated by the inhibition of IkappaB 
kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 
induction in mouse BV-2 microglia. Eur J Pharmacol (2005) 521(1–3):9–20. 
doi:10.1016/j.ejphar.2005.08.005 
27. Uetsuki T, Takemoto K, Nishimura I, Okamoto M, Niinobe M, Momoi T, et al. 
Activation of neuronal caspase-3 by intracellular accumulation of wild-type 
Alzheimer amyloid precursor protein. J Neurosci (1999) 19(16):6955–64. 
28. Williams RJ, Spencer JP. Flavonoids, cognition, and dementia: actions, mech-
anisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol 
Med (2012) 52(1):35–45. doi:10.1016/j.freeradbiomed.2011.09.010 
29. Oh-hashi K, Maruyama W, Yi H, Takahashi T, Naoi M, Isobe K. Mitogen-
activated protein kinase pathway mediates peroxynitrite-induced apoptosis 
in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res 
Commun (1999) 263(2):504–9. doi:10.1006/bbrc.1999.1237 
30. Oh-Hashi K, Maruyama W, Isobe K. Peroxynitrite induces GADD34, 45, and 
153 VIA p38 MAPK in human neuroblastoma SH-SY5Y cells. Free Radic Biol 
Med (2001) 30(2):213–21. doi:10.1016/S0891-5849(00)00461-5 
31. Muñoz-González I, Jiménez-Girón A, Martín-Álvarez PJ, Bartolomé B, 
Moreno-Arribas MV. Profiling of microbial-derived phenolic metabolites 
in human feces after moderate red wine intake. J Agric Food Chem (2013) 
61(39):9470–9. doi:10.1021/jf4025135 
32. Boto-Ordóñez M, Urpi-Sarda M, Queipo-Ortuño MI, Corella D, Tinahones 
FJ, Estruch R, et  al. Microbial metabolomic fingerprinting in urine after 
regular dealcoholized red wine consumption in humans. J Agric Food Chem 
(2013) 61(38):9166–75. doi:10.1021/jf402394c 
33. Arai K, Lee SR, van Leyen K, Kurose H, Lo EH. Involvement of ERK MAP 
kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma 
cells. J Neurochem (2004) 89(1):232–9. doi:10.1111/j.1471-4159.2004.02317.x 
34. Maruyama W, Kato Y, Yamamoto T, Oh-hashi K, Hashizume Y, Naoi M. 
Peroxynitrite induces neuronal cell death in aging and age-associated disorders: 
a review. J Am Aging Assoc (2001) 24(1):11–8. doi:10.1007/s11357-001-0002-8 
35. Park S, Geddes TJ, Javitch JA, Kuhn DM. Dopamine prevents nitration of 
tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine 
formation an early step in dopamine neuronal damage? J Biol Chem (2003) 
278(31):28736–42. doi:10.1074/jbc.M304362200 
36. Carrasco-Pozo C, Gotteland M, Castillo RL, Chen C. 3,4-Dihydroxyphenylacetic 
acid, a microbiota-derived metabolite of quercetin, protects against 
pancreatic β-cells dysfunction induced by high cholesterol. Exp Cell Res (2015) 
334(2):270–82. doi:10.1016/j.yexcr.2015.03.021 
37. Xue H, Xie W, Jiang Z, Wang M, Wang J, Zhao H, et al. 3,4-Dihydroxyphenylacetic 
acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen 
(APAP)-induced liver injury through activation of Nrf-2. Xenobiotica (2016) 
46(10):931–9. doi:10.3109/00498254.2016.1140847 
38. González-Sarrias A, Núñez-Sánchez MA, Tomás-Barberán FA, Espín JC. 
Neuroprotective effects of bioavailable polyphenol-derived metabolites against 
oxidative stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells. 
J Agric Food Chem (2017) 65(4):752–8. doi:10.1021/acs.jafc.6b04538 
39. Spencer JP, Schroeter H, Crossthwaithe AJ, Kuhnle G, Williams RJ, 
Rice-Evans C. Contrasting influences of glucuronidation and O-methylation 
of epicatechin on hydrogen peroxide-induced cell death in neurons 
and fibroblasts. Free Radic Biol Med (2001) 31(9):1139–46. doi:10.1016/
S0891-5849(01)00704-3 
40. Morand C, Manach C, Crespy V, Remesy C. Quercetin 3-O-beta-glucoside is 
better absorbed than other quercetin forms and is not present in rat plasma. 
Free Radic Res (2000) 33(5):667–76. doi:10.1080/10715760000301181 
41. Vauzour D, Vafeiadou K, Corona G, Pollard SE, Tzounis X, Spencer JP. 
Champagne wine polyphenols protect primary cortical neurons against 
peroxynitrite-induced injury. J Agric Food Chem (2007) 55(8):2854–60. 
doi:10.1021/jf063304z 
42. Vauzour D, Corona G, Spencer JP. Caffeic acid, tyrosol and p-coumaric acid 
are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Arch 
Biochem Biophys (2010) 501(1):106–11. doi:10.1016/j.abb.2010.03.016 
43. Klotz LO, Sies H. Defenses against peroxynitrite: selenocompounds 
and flavonoids. Toxicol Lett (2003) 140-141:125–32. doi:10.1016/
S0378-4274(02)00511-8 
44. Takeda K, Ichijo H. Neuronal p38 MAPK signaling: an emerging regulator of 
cell fate and function in the nervous system. Genes Cells (2002) 7(11):1099–111. 
doi:10.1046/j.1365-2443.2002.00591.x 
45. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK 
pathway by protein interactions. Biochem J (2000) 351:289–305. doi:10.1042/
bj3510289 
46. Wang X, Wang H, Xu L, Rozanski DJ, Sugawara T, Chan PH, et al. Significant 
neuroprotection against ischemic brain injury by inhibition of the MEK1 
protein kinase in mice: exploration of potential mechanism associated 
with apoptosis. J Pharmacol Exp Ther (2003) 304:172–8. doi:10.1124/
jpet.102.040246 
47. Pesse B, Levrand S, Feihl F, Waeber B, Gavillet B, Pacher P, et al. Peroxynitrite 
activates ERK via Raf-1 and MEK, independently from EGF receptor and 
p21Ras in H9C2 cardiomyocytes. J Mol Cell Cardiol (2005) 38(5):765–75. 
doi:10.1016/j.yjmcc.2005.02.020 
48. Lee YJ, Cho HN, Soh JW, Jhon GJ, Cho CK, Chung HY, et  al. Oxidative 
stress-induced apoptosis is mediated by ERK1/2 phosphorylation. Exp Cell 
Res (2003) 291(1):251–66. doi:10.1016/S0014-4827(03)00391-4 
49. Lan X, Liu R, Sun L, Zhang T, Du G. Methyl salicylate 2-O-β-d-lactoside, a 
novel salicylic acid analogue, acts as an anti-inflammatory agent on microglia 
and astrocytes. J Neuroinflammation (2011) 8:98. doi:10.1186/1742-2094-8-98 
50. Rendeiro C, Rhodes JS, Spencer JP. The mechanisms of action of flavonoids 
in the brain: direct versus indirect effects. Neurochem Int (2015) 89:126–39. 
doi:10.1016/j.neuint.2015.08.002 
51. Schroeter H, Bahia P, Spencer JP, Sheppard O, Rattray M, Cadenas E, et al. 
(-) Epicatechin stimulates ERK-dependent cyclic AMP response element 
activity and up-regulates GluR2 in cortical neurons. J Neurochem (2007) 
101(6):1596–606. doi:10.1111/j.1471-4159.2006.04434.x 
52. Warner EF, Zhang Q, Raheem KS, O’Hagan D, O’Connell MA, Kay CD. 
Common phenolic metabolites of flavonoids, but not their unmetabolized 
precursors, reduce the secretion of vascular cellular adhesion molecules 
by human endothelial cells. J Nutr (2016) 146(3):465–73. doi:10.3945/
jn.115.217943 
53. Song Y, Cui T, Xie N, Zhang X, Qian Z, Liu J. Protocatechuic acid improves 
cognitive deficits and attenuates amyloid deposits, inflammatory response 
in aged AβPP/PS1 double transgenic mice. Int Immunopharmacol (2014) 
20(1):276–81. doi:10.1016/j.intimp.2014.03.006 
54. Lee HS, Park DE, Song WJ, Park HW, Kang HR, Cho SH, et  al. Effect of 
1.8-cineole in dermatophagoides pteronyssinus-stimulated bronchial epithe-
lial cells and mouse model of asthma. Biol Pharm Bull (2016) 39(6):946–52. 
doi:10.1248/bpb.b15-00876 
12
Esteban-Fernández et al. Neuroprotective Effects of Wine Components
Frontiers in Nutrition | www.frontiersin.org March 2017 | Volume 4 | Article 3
55. Sabogal-Guáqueta AM, Osorio E, Cardona-Gómez GP. Linalool reverses 
neuropathological and behavioral impairments in old triple transgenic 
Alzheimer’s mice. Neuropharmacology (2016) 102:111–20. doi:10.1016/j.
neuropharm.2015.11.002 
56. Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. Flavonoids protect 
neurons from oxidized low-density-lipoprotein-induced apoptosis involving 
c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J (2001) 358(Pt 
3):547–57. doi:10.1042/0264-6021:3580547 
57. Hyman BT, Yuan J. Apoptotic and non-apoptotic roles of caspases in neu-
ronal physiology and pathophysiology. Nat Rev Neurosci (2012) 13:395–406. 
doi:10.1038/nrn3228 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 Esteban-Fernández, Rendeiro, Spencer, del Coso, de Llano, 
Bartolomé and Moreno-Arribas. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or licensor 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
